Home Cart Sign in  
Chemical Structure| 334-50-9 Chemical Structure| 334-50-9

Structure of Spermidine HCl
CAS No.: 334-50-9

Chemical Structure| 334-50-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Spermidine, a precursor of spermine, is a polyamine derived from putrescine and could help stabilize some membranes and nucleic acid structures.

Synonyms: Spermidine trihydrochloride; 4-Azaoctamethylenediamine trihydrochloride; Spermidine hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Spermidine HCl

CAS No. :334-50-9
Formula : C7H22Cl3N3
M.W : 254.63
SMILES Code : NCCCCNCCCN.[H]Cl.[H]Cl.[H]Cl
Synonyms :
Spermidine trihydrochloride; 4-Azaoctamethylenediamine trihydrochloride; Spermidine hydrochloride
MDL No. :MFCD00012918
InChI Key :LCNBIHVSOPXFMR-UHFFFAOYSA-N
Pubchem ID :9539

Safety of Spermidine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Isoform Comparison

Biological Activity

Description
Spermidine is essential for maintaining cell membrane stability, enhancing the activities of antioxidant enzymes, improving photosystem II (PSII), and upregulating relevant gene expression. It significantly reduces the contents of hydrogen peroxide (H2O2)[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary peritoneal macrophages 50 µM 1 hour Spermidine inhibited NLRP3 and pro-IL-1β expression and ROS generation Mol Med. 2022 Sep 4;28(1):103.
THP-1 macrophages 50 µM 1 hour Spermidine inhibited LPS-induced NLRP3 inflammasome activation and IL-1β production, and reduced NF-κB phosphorylation Mol Med. 2022 Sep 4;28(1):103.
BMDMs 10 mM 1 hourr To evaluate the impact of spermidine on phagocytic uptake, results showed that 10 mM spermidine significantly increased the phagocytic uptake of non-motile mutants. Elife. 2020 Sep 22;9:e55744.
Neonatal astrocytes 10 µM 18 hours To assess the effect of spermidine on astrocyte inflammatory response. Results showed that spermidine reduced the poly I:C-induced release of IL-6, TNF-α, IL-10, IL-12, IL-4 and KC/GRO. J Neuroinflammation. 2022 Jul 2;19(1):172.
RAW 264.7 cells 100 µM 24 hours Evaluate cytocompatibility, results indicate good cytocompatibility up to 100 μM of SPD. Adv Sci (Weinh). 2024 Jun;11(22):e2310162.
Human retinal pigment epithelial cells (ARPE-19) 10 µM 24 hours Spermidine significantly attenuated H2O2-induced cytotoxicity, apoptosis, and G2/M phase cell cycle arrest, and reduced mitochondrial dysfunction. Int J Mol Sci. 2021 Jan 29;22(3):1361.
H1299 cells 100 µM 4 hours and 16 hours To evaluate the effect of spermidine on NRF2 and autophagy pathways. Results showed that SPD increased the protein levels of MAP1S, p62, and NRF2 in a dose-dependent manner, and decreased KEAP1 protein levels. Hepatology. 2019 Jul;70(1):372-388.
Human vascular smooth muscle cells 0.1, 0.5, 1 µM 7 days Spermidine significantly reduced mineral deposition and inhibited osteogenic differentiation markers BMP2 and Runx2 expression Aging Cell. 2021 Jun;20(6):e13377.
Rat vascular smooth muscle cells 0.1, 0.5, 1 µM 7 days Spermidine significantly reduced mineral deposition and inhibited osteogenic differentiation markers BMP2 and Runx2 expression Aging Cell. 2021 Jun;20(6):e13377.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Drosophila DSms/C0//C0 Drosophila Oral 10 mM Continuous administration DFMO extended the lifespan of dSms/C0//C0 Drosophila, with median survival of male flies increasing from 21 to 35 days. EMBO Mol Med. 2023 Nov 8;15(11):e17833
C57BL/6J mice High-fat diet-induced obese Mice model Oral 20 mg/kg Once daily for 14 weeks To evaluate the ameliorative effects of spermidine on metabolic syndrome, results showed spermidine significantly reduced body weight, improved lipid profiles and insulin sensitivity, and promoted white adipose tissue browning Nat Commun. 2025 Jan 21;16(1):877
Sprague-Dawley rats Middle-aged rat model Drinking water 25 mg/kg Daily administration for 350 days To assess the effect of spermidine on behavioral performance and longevity of middle-aged rats. Results showed that spermidine did not significantly extend lifespan but improved body weight, kidney, liver, and heart morphology, reduced anxiety and increased exploratory behavior, enhanced brain autophagy, and decreased expression of inflammatory markers. Geroscience. 2020 Jun;42(3):937-949
Rats Subcutaneous implantation model Subcutaneous implantation 250 μM Single implantation, observed up to 21 days Evaluate the immunomodulatory effects of DN-SPD hydrogel, results show DN-SPD hydrogel significantly reduced inflammatory responses and fibrous encapsulation. Adv Sci (Weinh). 2024 Jun;11(22):e2310162.
Mice CCl4-induced liver fibrosis model Drinking water 3 mM 5 weeks To assess the protective effect of spermidine on liver fibrosis. Results showed that SPD significantly alleviated CCl4-induced liver fibrosis, and this protective effect was significantly reduced in NRF2 or p62 single knockout mice and completely abolished in double knockout mice. Hepatology. 2019 Jul;70(1):372-388.
Mice APPPS1 mice Oral 3 mM Starting at 30 days of age until 120 or 290 days of age To assess the effect of spermidine on AD pathology. Results showed that spermidine significantly reduced soluble Aβ40 and Aβ42 levels, decreased neuroinflammation, and altered microglial transcriptome and proteome. J Neuroinflammation. 2022 Jul 2;19(1):172.
Rats Chronic kidney disease model Drinking water 3 mM For 4 weeks Spermidine significantly attenuated aortic calcification, reduced calcium content, and inhibited osteogenic differentiation markers BMP2 and Runx2 expression Aging Cell. 2021 Jun;20(6):e13377.
C57BL/6 mice Sepsis-induced acute kidney injury model Drinking water 3 mM Started 1 week before LPS treatment Spermidine improved sepsis-induced acute kidney injury by modulating macrophage NLRP3 inflammasome activation and mitochondrial respiration Mol Med. 2022 Sep 4;28(1):103.
Mice ALS (G93A) transgenic mice Intraperitoneal injection 5 mg/kg 4 times per week, from 30 to 120 days of age Spermidine improved motor neuron survival and neuropathology in ALS mice, delayed disease onset, and prolonged lifespan J Biomed Sci. 2022 Dec 20;29(1):106
C57BL/6 mice Sepsis-induced acute kidney injury model Intraperitoneal injection 50 mg/kg Started 30 min or 24 h after LPS treatment, once daily Spermidine improved sepsis-induced acute kidney injury by modulating macrophage NLRP3 inflammasome activation and mitochondrial respiration Mol Med. 2022 Sep 4;28(1):103.
C57BL/6 mice B16F10 melanoma model Intraperitoneal injection 75 mg/kg Single administration Spermidine inhibited anti-CD3/CD28-induced CD8+ T cell activation and proliferation Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2305245120

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.93mL

0.79mL

0.39mL

19.64mL

3.93mL

1.96mL

39.27mL

7.85mL

3.93mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories